
đ§Ź Rabia Khan - Serna Bio: Unraveling the Genetics of AI-Driven Drug Discovery (Part 1/4)
04/14/25 ⢠48 min
- Formative Influences: Shaped by Pakistan upbringing, aunt's schizophrenia, and genome sequencing
- Educational Journey: Balancing biology and economics at McGill
- First Research Experiences: From lab basics to discovering a disease-causing gene
- Decision-Making Frameworks: Applying economics principles to business decisions
- Family Influence: Mother's practicality and father's entrepreneurial drive guided her path
- Formative Influences: Shaped by Pakistan upbringing, aunt's schizophrenia, and genome sequencing
- Educational Journey: Balancing biology and economics at McGill
- First Research Experiences: From lab basics to discovering a disease-causing gene
- Decision-Making Frameworks: Applying economics principles to business decisions
- Family Influence: Mother's practicality and father's entrepreneurial drive guided her path
Previous Episode

đ§ŹAlfredo Andere - LatchBio: Revolutionizing Biopharma Data & Mastering Enterprise Sales (Part 4/4)
đ§Ź The Biotech Startups Podcast is powered by Excedr âhelping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science.As a TBSP listener, you can get exclusive perks through Excedrâs partner networkâspecial savings, promotions, and more. Explore these offers today: https://www.excedr.com/partners."Focus and commitment to niche ideas have huge payoffs."In part four of our conversation with Alfredo Andere, co-founder of LatchBio, we explore how the company evolved from a simple workflow orchestrator into a comprehensive platform serving biopharma companies and solution providers. Alfredo shares his approach to enterprise sales, emphasizing the importance of speed, focus, and building strong relationships with customers. He also delves into his philosophy on fundraising and the pivotal role of iterative development in creating impactful biotech solutions.Alfredo reflects on the challenges and rewards of working in niche markets, explaining why deep commitment and loyalty to specific problems are essential for long-term success. Whether youâre a first-time founder or an experienced entrepreneur, this episode is packed with actionable insights on building, selling, and scaling in the biotech space.Key topics covered:
- Iterative product development: Expanding LatchBioâs platform from workflows to data storage and analysis
- Biopharma vs. solution providers: How LatchBio serves these distinct customer groups
- Enterprise sales best practices: Qualifying leads and acting as a consultant to customer problems
- Fundraising strategies: Why early-stage rounds focus on vision and team, while later rounds prioritize traction
- The power of focus: Avoiding the trap of optionality and scaling only when ready
Next Episode

đ§Ź Rabia Khan - Serna Bio: Bridging Science & TechâPhDs, MBAs, & Biotech Innovation (Part 2/4)
đ§Ź The Biotech Startups Podcast is powered by Excedr âhelping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science.As a TBSP listener, you can get exclusive perks through Excedrâs partner networkâspecial savings, promotions, and more. Explore these offers today: https://www.excedr.com/partners.âI wish someone had told me when I was starting my PhD to sit down and say, âwhat do I want out of this?â and [then] write it down. Because, unlike the UK, where PhDs are three years and time bound, in Canada, they are neither time bound nor three years. And so you can meander."
In this episode of The Biotech Startups Podcast, Rabia Khan, founder and CEO of Serna Bio, joins host Jon Chee to reflect on her unconventional journey through academia, business, and biotech innovation. Rabia shares how her curiosity, resilience, and embracing uncertainty shaped her journey through a PhD in genetics and an MBA. She discusses the emotional challenges of working with animal models, the benefits and limits of business school for scientists, and personal struggles, including her fatherâs illness.She recounts early setbacks, like rejected consulting jobs, and how a cold email landed her at Meta (now part of Chan Zuckerberg Biohub). Rabia emphasizes âmanufacturing serendipity,â differences between founder and employee mindsets, and lessons from her work at BenevolentAI, highlighting the importance of cross-disciplinary communication and challenging industry norms.Key topics covered:
- PhD Realities: Tackling emotional and practical research challenges
- Dual-Degree Insights: Balancing PhD and MBA, knowing business limits
- Personal Adversity: Turning family illness into resilience
- Career Breakthroughs: Creating and seizing biotech startup chances
- Bridging Disciplines: Fusing biology and ML to expand drug targets
If you like this episode youâll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/the-biotech-startups-podcast-273960/rabia-khan-serna-bio-unraveling-the-genetics-of-ai-driven-drug-discov-89600463"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to đ§Ź rabia khan - serna bio: unraveling the genetics of ai-driven drug discovery (part 1/4) on goodpods" style="width: 225px" /> </a>
Copy